These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 22143497)

  • 1. Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity.
    Nogueira LM; Dunlap SM; Ford NA; Hursting SD
    Endocr Relat Cancer; 2012 Feb; 19(1):57-68. PubMed ID: 22143497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.
    De Angel RE; Conti CJ; Wheatley KE; Brenner AJ; Otto G; Degraffenried LA; Hursting SD
    Mol Carcinog; 2013 Jun; 52(6):446-58. PubMed ID: 22290600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors.
    Dogan S; Johannsen AC; Grande JP; Cleary MP
    Nutr Cancer; 2011; 63(3):389-401. PubMed ID: 21462085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice.
    Cleary MP; Jacobson MK; Phillips FC; Getzin SC; Grande JP; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):836-43. PubMed ID: 12223427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer.
    Lashinger LM; Malone LM; Brown GW; Daniels EA; Goldberg JA; Otto G; Fischer SM; Hursting SD
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1041-51. PubMed ID: 21593197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones.
    Nunez NP; Perkins SN; Smith NC; Berrigan D; Berendes DM; Varticovski L; Barrett JC; Hursting SD
    Nutr Cancer; 2008; 60(4):534-41. PubMed ID: 18584488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1.
    Nogueira LM; Lavigne JA; Chandramouli GV; Lui H; Barrett JC; Hursting SD
    Cancer Med; 2012 Oct; 1(2):275-88. PubMed ID: 23342276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary restriction permits normal parturition and lactation but suppresses mouse mammary tumor virus proviral transcription even after mammary involution.
    Engelman RW; Fukaura Y; Hamada N; Good RA; Day NK
    Cancer Res; 1991 Oct; 51(19):5123-8. PubMed ID: 1655246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer.
    De Angel RE; Smith SM; Glickman RD; Perkins SN; Hursting SD
    Nutr Cancer; 2010; 62(8):1074-86. PubMed ID: 21058195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum insulin-like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTV-TGF-alpha mice.
    Rogozina OP; Bonorden MJ; Grande JP; Cleary MP
    Cancer Prev Res (Phila); 2009 Aug; 2(8):712-9. PubMed ID: 19654106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of moderate caloric restriction and/or weight cycling on mammary tumor incidence and latency in MMTV-Neu female mice.
    Pape-Ansorge KA; Grande JP; Christensen TA; Maihle NJ; Cleary MP
    Nutr Cancer; 2002; 44(2):162-8. PubMed ID: 12734063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues.
    Moore T; Beltran L; Carbajal S; Strom S; Traag J; Hursting SD; DiGiovanni J
    Cancer Prev Res (Phila); 2008 Jun; 1(1):65-76. PubMed ID: 19138937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-carbohydrate diet versus caloric restriction: effects on weight loss, hormones, and colon tumor growth in obese mice.
    Wheatley KE; Williams EA; Smith NC; Dillard A; Park EY; Nunez NP; Hursting SD; Lane MA
    Nutr Cancer; 2008; 60(1):61-8. PubMed ID: 18444137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of mammary tumorigenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response?
    Cleary MP; Hu X; Grossmann ME; Juneja SC; Dogan S; Grande JP; Maihle NJ
    Exp Biol Med (Maywood); 2007 Jan; 232(1):70-80. PubMed ID: 17202587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF1 dependence of dietary energy balance effects on murine Met1 mammary tumor progression, epithelial-to-mesenchymal transition, and chemokine expression.
    Ford NA; Nunez NP; Holcomb VB; Hursting SD
    Endocr Relat Cancer; 2013 Feb; 20(1):39-51. PubMed ID: 23152442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer.
    Ford NA; Rossi EL; Barnett K; Yang P; Bowers LW; Hidaka BH; Kimler BF; Carlson SE; Shureiqi I; deGraffenried LA; Fabian CJ; Hursting SD
    Cancer Prev Res (Phila); 2015 Sep; 8(9):796-806. PubMed ID: 26100521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy balance, physical activity, and cancer risk.
    Fair AM; Montgomery K
    Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
    Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal biomarker investigation on efficacy and mechanism of action for the mammalian target of rapamycin inhibitor, temsirolimus, in a preclinical mammary carcinoma OncoMouse model: a translational medicine study in support for early clinical development.
    Wang X; Zhan Y; Zhao L; Alvarez J; Chaudhary I; Zhou BB; Abraham RT; Feuerstein GZ
    J Pharmacol Exp Ther; 2011 Nov; 339(2):421-9. PubMed ID: 21835932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
    Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
    Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.